Legal, Disclaimers & Privacy

All content on this website — including text, diagrams, product descriptions, capability claims, comparison tables, workflow descriptions, and technical documentation — is provided "as is" for general informational purposes only.

DIIaC Ltd makes no representations or warranties, express or implied, as to the accuracy, completeness, fitness for purpose, or timeliness of any information on this site. Content may be updated, corrected, or removed at any time without notice.

Nothing on this website constitutes or shall be construed as a contractual commitment, offer, warranty, service level agreement, or binding specification. Product capabilities described on this site are indicative and subject to change as development progresses.

DIIaC™ provides governed decision infrastructure. Outputs from the platform — including decision packs, board reports, evidence summaries, governance manifests, signed artefacts, and advisory outputs — constitute structured governance artefacts intended for human review. They do not constitute:

• Autonomous decisions or autonomous decision-making
• Professional, legal, financial, regulatory, or clinical advice
• Regulatory certification, approval, or compliance assurance
• Audit opinions or formal assurance engagements
• Scientific conclusions, clinical recommendations, or medical guidance

All decision authority remains with the accountable human reviewer. No platform output should be acted upon without explicit human review, validation, and sign-off by appropriately qualified personnel with the relevant organisational and regulatory context.

Content on this site is not legal advice and does not create a solicitor-client or any other professional relationship. References to legislation, regulatory frameworks, or legal obligations are provided for general context only. You should seek independent legal advice in relation to your specific circumstances.

References to regulatory frameworks (including but not limited to EU AI Act, EU GMP Annexes, MHRA GxP, ICH guidelines, EMA GVP, GDPR, NIS2, UK AI Governance) are provided for informational context only. DIIaC™ does not certify compliance with any regulatory framework. Organisations are responsible for their own regulatory compliance assessments, submissions, and obligations, and should seek appropriately qualified regulatory advice.

Nothing on this website or produced by the DIIaC™ Pharma build constitutes medical, clinical, pharmacological, or scientific advice. Platform outputs in the Pharma build — including PRIA advisory outputs, research-readiness assessments, evidence catalogue entries, and governance packs — are advisory and informational only. They do not constitute clinical recommendations, diagnostic guidance, treatment decisions, or drug development advice. All such decisions require appropriately qualified human scientific and clinical review.

Nothing on this website constitutes financial advice, investment advice, or a prospectus. DIIaC Ltd is not authorised to provide financial advice. Any commercial or investment decisions should be made with appropriate independent professional advice.

All intellectual property rights in this website and in the DIIaC™ platform — including but not limited to the platform architecture, governance pipeline design, evidence model framework, cryptographic signing methodology, policy pack structure, artefact family design, PRIA advisory layer, and all associated software, documentation, and branding — are owned by or licensed to DIIaC Ltd.

DIIaC™ is a trademark of DIIaC Ltd. Unauthorised use of this mark, or any confusingly similar mark, is prohibited.

This website does not disclose, and is not intended to disclose, any of the following proprietary information of DIIaC Ltd:

• Proprietary algorithms, scoring models, or inference logic
• Source code, compiled code, or platform binaries
• Internal pipeline logic, compilation pathways, or gate logic
• Cryptographic implementation details, key management architecture, or signing infrastructure
• Infrastructure specifics, cloud configuration, or deployment architecture
• Tenant configuration, customer data, or customer decision outputs
• Unreleased product roadmaps or commercial terms

Information published on this website describes platform capabilities and governance architecture at a product-level only. Any apparent description of implementation detail is for illustrative purposes and does not constitute disclosure of confidential technical information.

You may access and read the content of this website for personal, non-commercial informational purposes. You may not copy, reproduce, republish, upload, post, transmit, or distribute any content from this website for any commercial purpose without the prior written consent of DIIaC Ltd.

References to third-party products, platforms, frameworks, and organisations on this website (including but not limited to ServiceNow, IBM, Microsoft, Veeva, Medidata, Oracle, Benchling, Credo AI, OneTrust, ValidMind) are for informational context only. Such references do not imply endorsement, partnership, or affiliation. All third-party names, trademarks, and intellectual property remain the property of their respective owners.

Descriptions of platform capabilities, decision domains, evidence models, regulatory controls, and governance features on this website describe the platform as it is designed and being developed. Capability availability may vary and is subject to change without notice. Not all described capabilities may be available at any given point in the development lifecycle.

The competitive comparison table on the platform page is based on DIIaC Ltd's review of publicly available vendor documentation as of March–May 2026. It is provided for general informational context only and is not intended to be exhaustive, authoritative, or current. Vendor capabilities change frequently. The comparison:

• Is not a procurement evaluation or formal market assessment
• Should not be relied upon in regulated procurement processes without independent verification
• May not reflect current vendor capabilities at the time of reading
• Is not endorsed by, affiliated with, or verified by any of the third-party vendors named

Proof points listed on this website reflect the state of the platform at the time of publication and are subject to change. They are provided in good faith based on internal development and testing and should not be construed as externally audited, certified, or independently verified statements.

The DIIaC™ platform is designed to support human decision-making, not replace it. All platform outputs are structured artefacts intended for human review. The platform does not make binding decisions, take autonomous action, or operate without a defined human accountability state.

This website describes the nature of the DIIaC™ platform, its governance approach, and the intended use of its outputs. Users of the platform are informed that its outputs are AI-assisted governance artefacts requiring human review.

DIIaC™ is a decision governance infrastructure tool. It is not a general-purpose AI system. Platform-specific AI system classification, risk assessment, and deployer obligations are the responsibility of each customer organisation deploying the platform in their regulated environment, consistent with applicable AI governance frameworks.

M² is an advisory interpretability and behavioural-review layer for governed decision artefacts. It helps reviewers inspect structure, salience, and divergence signals across DIIaC outputs. M² outputs are review aids only and are not independent audit findings, certification, legal advice, scientific proof, model-truth guarantees, or autonomous approval signals.

M² does not approve or reject decisions, certify factual accuracy, inspect all upstream model internals, mutate signed packs, or override DIIaC evidence, approval, signatures, verifier, replay, Merkle integrity, or ledger controls. Final reliance remains governed by DIIaC evidence state, named human approval, organisational procedures, and applicable customer controls.

PRIA (Pharmaceutical Research Intelligence Advisory) outputs are advisory only in all circumstances. PRIA does not and cannot:

• Approve, certify, or validate drug targets, lead compounds, or drug candidates
• Authorise progression from any preclinical to clinical stage
• Constitute or replace human scientific review at any stage
• Generate regulatory submissions or dossier content
• Provide clinical opinions, diagnoses, or treatment recommendations
• Establish scientific truth or authoritative scientific conclusions

Every PRIA output requires mandatory human scientific review by appropriately qualified personnel before any action is taken in reliance on it.

References to GxP, Annex 11/15, ALCOA+, ICH E6, EMA GVP, EU CTR, and other regulatory frameworks describe governance controls designed into the Pharma build. They do not constitute regulatory advice, GxP validation, formal compliance assessment, or regulatory authority guidance. Customer organisations are solely responsible for their own regulatory compliance, validation programmes, and regulatory submissions.

The GxP validation baseline documentation (URS, FRS, Design Specification, Requirements Traceability Matrix, Validation Plan, IQ/OQ/PQ framework) provided with the Pharma build is a structured starting point only. It does not constitute executed validation evidence. Formal system qualification requires customer-executed validation activities, customer-generated evidence, and customer-controlled approval processes under applicable GxP requirements.

The DIIaC™ Pharma build sits above and alongside operational systems of record. It does not replace or substitute for GxP-validated systems of record, pharmacovigilance databases, clinical trial management systems, electronic trial master file systems, quality management systems, laboratory information management systems, electronic data capture systems, electronic lab notebooks, or any other regulated system. The regulatory functions of such systems are not affected by DIIaC™.

To the fullest extent permitted by applicable law, DIIaC Ltd excludes all representations, warranties, conditions, and terms, whether express or implied, in relation to this website and its content, including without limitation any implied warranty of accuracy, fitness for a particular purpose, or non-infringement.

DIIaC Ltd shall not be liable for any loss or damage — whether direct, indirect, consequential, incidental, special, or punitive — arising from or in connection with:

• Access to or use of this website or any information contained in it
• Reliance on any content, capability description, or comparison information on this site
• Any decision made or action taken in reliance on platform outputs without appropriate human review
• Any inaccuracy, error, or omission in the content of this website
• Interruption, suspension, or unavailability of this website
• Any third-party content linked to or referenced on this site

Nothing in these notices excludes or limits DIIaC Ltd's liability for death or personal injury caused by negligence, fraud or fraudulent misrepresentation, or any other liability that cannot be excluded or limited under applicable law.

This website is currently an informational site only. It does not:

• Collect personal data through forms, registration, or account creation
• Process payment or financial information
• Require login or authentication
• Process any customer decision data or tenant information

As with all websites, web server infrastructure may log standard access data including IP addresses, browser type, referring URL, and page access times for operational and security purposes. This data is processed under legitimate interest grounds for website security and performance monitoring and is not used for marketing, profiling, or shared with third parties for commercial purposes.

This website loads fonts from Google Fonts (fonts.googleapis.com). This may result in your IP address and browser information being transmitted to Google's servers. Google's privacy policy governs this processing. If you prefer, you can block requests to Google Fonts through your browser or privacy tools.

When the DIIaC™ platform is made available to customers, a full Data Processing Agreement and Privacy Notice will be provided as part of the customer onboarding process. Platform data processing will be governed by applicable data protection law including UK GDPR and, where applicable, EU GDPR. Customer data will not be used to train general-purpose models or shared with third parties without explicit customer authorisation.

Under UK GDPR and applicable data protection law, individuals have rights including the right to access, rectify, erase, and restrict processing of personal data held about them. As this website currently collects no identifiable personal data, there is generally nothing held to action. For any data protection queries, contact DIIaC Ltd at the address below.

DIIaC Ltd is the data controller for this website. Registered in England and Wales.